Food and Drug Administration

Pulmonary-Allergy Drugs Advisory Committee

June 14, 2005

Briefing Information



Portions of this document have been determined to be exempt from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. 552)
These redacted portions will appear as white space on the screen or on the printed page.

FDA Briefing Material TOC